Physician profile
Aniela Maggio
NPI 1841744257
$483.72
in general payments reported to CMS, 2019-2025
14 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $65.54 · 2022: $22.83 · 2023: $106 · 2024: $99.00 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $81.05 | 2023-2024 | |
| Abbvie INC. | $63.35 | 2021-2025 | |
| Vertex Pharmaceuticals Incorporated | $58.38 | 2024-2025 | |
| Janssen Biotech, INC. | $48.49 | 2024-2025 | Simponi, Simponi Aria, Stelara |
| Exact Sciences Corporation | $41.95 | 2023-2024 | Cologuard Collection Kit |
| Ardelyx, INC. | $35.76 | 2025 | Ibsrela |
| Intuitive Surgical, INC. | $27.00 | 2025 | |
| Coopersurgical, INC. | $25.03 | 2025 | Paragard T 380a |
| Urovant Sciences INC | $22.83 | 2022 | |
| Exeltis, USA INC. | $19.80 | 2021 | |
| Resmed Corp | $16.82 | 2025 | |
| Shield Therapeutics INC | $15.57 | 2023 | Accrufer |
| Takeda Pharmaceuticals U.S.A., INC. | $14.57 | 2025 | Entyvio |
| Pfizer INC. | $13.12 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aniela Maggio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.